Background: New vaccination strategies are needed to control the increasing problem of
pertussis in teenagers and adults. Aim: To determine the immunogenicity and reactogenicity …

[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …

A trial to compare the reactogenicity and immunogenicity of a reduced antigen content
diphtheria–tetanus–acellular pertussis (dTpa) vaccine with diphtheria–tetanus–whole-cell …

Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …

The aim of this assessor-blinded trial was to compare the immunogenicity and reactogenicity
of a candidate diphtheria, tetanus toxoids and acellular pertussis vaccine with reduced …

The present study was undertaken to compare the immunogenicity and reactogenicity of two
diphtheria-tetanus-whole cell pertussis (DTwP) vaccines administered to Iranian preschool …

The Argentine vaccination schedule against diphtheria, tetanus and pertussis (DTP)
recommends three doses of DTP vaccine at 2, 4 and 6 months of age, two boosters at 18 …

BACKGROUND. The incidence of pertussis is increasing, especially in adolescents,
attributed in part to waning of immunity after childhood immunization. Recently licensed in …

Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …

PURPOSE: Disease caused by Bordetella pertussis is increasingly being identified among
older children and adults in immunized populations, indicating a waning of the vaccine …